OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Allergy and Clinical Immunology is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Clinical phenotypes of adult atopic dermatitis and related therapies	40
Vaccine allergy: evidence to consider for COVID-19 vaccines	32
Vernal keratoconjunctivitis and keratoconus	27
Omalizumab as monotherapy for food allergy	26
Update on omalizumab in allergen immunotherapy	26
Omalizumab as an adjuvant in food allergen immunotherapy	24
COVID-19 and X-linked agammaglobulinemia (XLA) – insights from a monogenic antibody deficiency	23
Small-airway dysfunction in paediatric asthma	23
Artificial stone silicosis	22
Mechanisms underlying host defense and disease pathology in response to severe acute respiratory syndrome (SARS)-CoV2 infection: insights from inborn errors of immunity	21
Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host–environmental interactions	20
Epithelial-to-mesenchymal transition in neutrophilic chronic rhinosinusitis	19
Autologous serum eye drops for ocular surface disorders	18
Cleaners and airway diseases	18
COVID-19 in complex common variable immunodeficiency patients affected by lung diseases	18
Choice of biologics in asthma endotypes	18
Antibody therapy for COVID-19	17
Cow's milk allergy	17
Role of clinical history in beta-lactam hypersensitivity	16
Application of exhaled nitric oxide (FeNO) in pediatric asthma	15
COVID-19 and autoimmune diseases: is there a connection?	15
Novel vaccines for allergen-specific immunotherapy	15
Gastroesophageal reflux and asthma: when, how, and why	14
Inflammatory endotypes of CRSwNP and responses to COVID-19	14
Air pollution and childhood asthma	13

Pediatric asthma in developing countries: challenges and future directions	12
Asthma, severe acute respiratory syndrome coronavirus-2 and coronavirus disease 2019	12
Allergen immunotherapy and biologics in respiratory allergy: friends or foes?	12
The impact of obesity on immune function in pediatric asthma	12
Fractional exhaled nitric oxide and asthma treatment adherence	12
Epidemiology of anaphylaxis	12
Probiotics in food allergy	11
Alpha1-antitrypsin deficiency and asthma	11
Resolving the genetics of human tryptases: implications for health, disease, and clinical use as a biomarker	10
Predicting the course of asthma from childhood until early adulthood	10
Basophil activation test in food allergy: is it ready for real-time?	10
Biologics and severe asthma in children	9
Emerging approaches in the diagnosis and therapy in shellfish allergy	9
Grading the severity of anaphylaxis	9
Real-life studies in allergen immunotherapy	9
Impact of the exposome on food allergy development	9
Nucleic acid vaccines and CpG oligodeoxynucleotides for allergen immunotherapy	9
Exploring the origin and regulatory role of mast cells in asthma	9
An update on the epigenetics of asthma	9
Role of tissue-resident memory T cells in the pathophysiology of allergic contact dermatitis	8
Update on irritant-induced occupational asthma	8
Drug allergy management in the elderly	8
How E-cigarettes and vaping can affect asthma in children and adolescents	8
Mast cell activation syndrome: is anaphylaxis part of the phenotype? A systematic review	8
Neutrophilic inflammation in chronic rhinosinusitis	8
Anaphylaxis across Europe: are pollen food syndrome and lipid transfer protein allergy so far apart?	8
Chronic rhinosinusitis: phenotypes and endotypes	8
Biologics for eosinophilic granulomatosis with polyangiitis	8
Clinical and biological markers in disease and biologics to treat chronic rhinosinusitis	8
Exhaled nitric oxide in asthma: from diagnosis to management	8
Occupational inhalant allergy in food handling occupations	8
Cellular interactions in aspirin-exacerbated respiratory disease	7
Biologicals for the prevention of anaphylaxis	7
Nanoparticles in allergen immunotherapy	7
Atopic dermatitis endotypes: knowledge for personalized medicine	7
Classifying cephalosporins: from generation to cross-reactivity	7
A review of food allergy-related costs with consideration to clinical and demographic factors	7
Biologics as treatment options for anaphylaxis	7
Food-labeling issues for severe food-allergic consumers	7
Is asthma a risk factor for coronavirus disease-2019 worse outcomes? The answer is no, but …	7
Updates in diagnosis and management of paediatric mastocytosis	6
Anaphylaxis in elderly people	6
Wheat oral immunotherapy	6
Strengthening the case for intralymphatic immunotherapy	6
Pulmonary function testing for the diagnosis of asthma in preschool children	6
Evaluating the glucagon-like peptide-1 receptor in managing asthma	6
New insights into the diagnosis and management of Stevens–Johnson syndrome and toxic epidermal necrolysis	6
Occupational respiratory and skin diseases among workers exposed to metalworking fluids	6
Management of adverse reactions induced by chemotherapy drugs	6
Allergy prevention through breastfeeding	6

Safety of anti-inflammatory drugs in children with asthma	6
Anaphylaxis and digital medicine	6
Global patterns of drug allergy-induced fatalities: a wake-up call to prevent avoidable deaths	6
Recent advances in the diagnosis and management of tree nut and seed allergy	6
Paediatric allergy practice in the era of coronavirus disease 2019	6
Current strategies for phenotyping and managing asthma in preschool children	6
Gene therapy for inborn error of immunity – current status and future perspectives	6